JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, published by Springer, is a premier journal dedicated to advancing our understanding of muscle biology and cellular motility. With an ISSN of 0142-4319 and an E-ISSN of 1573-2657, this journal stands out in the fields of biochemistry, cell biology, and physiology, proudly holding a Q2 ranking in each of these categories as per 2023 metrics. Covering significant developments from its inception in 1963 to its anticipated contributions through 2024, this journal serves as a vital platform for researchers and professionals to disseminate their findings and insights globally. Although it does not currently offer open access, its robust academic rigor and relevance are evident from its Scopus rankings, making it a crucial resource for those invested in the biological sciences. With a focus on original research articles, reviews, and methodological advancements, the journal fosters innovative collaborations and discussions within the scientific community, making it an invaluable addition to any researcher’s library.

The American Journal of Physiology - Renal Physiology (ISSN: 1931-857X; E-ISSN: 1522-1466), published by the esteemed American Physiological Society, serves as a premier platform for disseminating significant research in the field of renal physiology. This journal, recognized for its high impact factor and classified in the Q1 category for both Physiology and Urology as of 2023, showcases innovative studies, reviews, and critical commentaries that deepen our understanding of kidney function and its implications on overall health. With coverage extending from 1977 to 2024, the journal is crucial for researchers, clinicians, and students who are eager to explore the latest findings and advancements in renal research. Although it does not provide Open Access options, the journal's commitment to rigorous peer review ensures that only the highest quality of scientific inquiry reaches its audience, solidifying its reputation as a vital resource in the field.

NEUROCHEMICAL RESEARCH, published by Springer/Plenum Publishers, is a pivotal journal in the fields of biochemistry, neuroscience, and cellular and molecular studies. With an impressive impact factor that positions it within the prestigious Q1 category in Biochemistry and Medicine and Q2 in Cellular and Molecular Neuroscience, it provides a robust platform for the dissemination of cutting-edge research findings. Since its inception in 1976, the journal has played a crucial role in bridging the gap between neurochemical processes and neurological health, making significant contributions to our understanding of brain function and disease. Researchers and professionals are encouraged to engage with a wealth of high-quality articles that not only advance the field but also inform clinical practices. Located in the heart of New York, the journal continues to uphold its reputation as a leader in promoting innovative research that is essential for both academic and applied sciences.

Microvascular Research is a prominent journal dedicated to advancing the understanding of microvascular biology and its implications in various health and disease contexts. Published by Academic Press Inc elsevier Science, this journal holds a significant place in the academic community with an impact factor reflecting its high citation frequency and relevance within its fields. With a Q2 ranking in both Biochemistry and Cardiology and Cardiovascular Medicine, as well as a Q3 ranking in Cell Biology, it provides an essential platform for researchers and professionals to publish and access groundbreaking studies. Established in 1968 and running through to 2025, Microvascular Research covers a broad scope, focusing on various topics related to microvessels and their functions, emphasizing the importance of these structures in health and pathology. Although the journal does not offer open access, it remains a vital resource for those seeking to deepen their understanding of microvascular dynamics, making it an essential addition to the libraries of researchers, clinicians, and students alike.

GENERAL PHYSIOLOGY AND BIOPHYSICS, published by AEPRESS SRO, is a pivotal journal in the fields of biophysics and physiology, dedicated to advancing knowledge and fostering research in these increasingly vital disciplines. Established in 1983 and set to converge in 2024, the journal provides a platform for scholarly articles that explore the intricate relationships between biological systems and physical principles. Its current category quartiles include Q3 in Biophysics and Q4 in Physiology, demonstrating a growing influence among researchers, with current Scopus ranks reflecting its commitment to quality and relevance. Despite not being an open-access publication, the journal remains a valuable resource for professionals and students aiming to stay informed on the latest discoveries and methodologies. By supporting interdisciplinary research and innovation, GENERAL PHYSIOLOGY AND BIOPHYSICS plays a crucial role in shaping the understanding of complex biological interactions and applications in medicine.

Function is a pioneering open access academic journal published by Oxford University Press, dedicated to advancing research in the fields of Cancer Research, Cell Biology, Molecular Medicine, and Physiology. Since its inception in 2020, this journal has quickly established itself as a vital resource for researchers and professionals alike, achieving a commendable impact factor in the 2023 rankings, where it stands in the Q2 quartile across multiple categories. Located in the heart of the United Kingdom, Function aims to foster a global exchange of knowledge by providing free and unrestricted access to cutting-edge research, facilitating collaboration and innovation within the scientific community. With a robust focus on emerging discoveries and interdisciplinary approaches, this journal encourages contributions that unravel the complexities of biological functions, paving the way for transformative advancements in healthcare and related sciences. As it converges from 2020 to 2024, Function continues to be an invaluable platform for disseminating research that has the potential to shape the future of medicine and biology.

Clinical Hemorheology and Microcirculation, published by IOS Press, is a distinguished journal dedicated to advancing the scientific understanding of blood flow mechanics and microcirculatory phenomena. Since its inception in 1991, the journal has been pivotal in bridging the fields of cardiology, hematology, and physiology, as evidenced by its placement in the Q3 quartile across several categories in 2023. Positioned in the vibrant academic landscape of the Netherlands, Clinical Hemorheology and Microcirculation offers valuable insights to researchers and practitioners alike, enriching their knowledge and fostering innovation in clinical practices. With an ISSN of 1386-0291 and an E-ISSN of 1875-8622, the journal serves as a vital platform for disseminating high-quality research and reviews that explore the intricate dynamics of blood viscosity and microvascular function, essential to both health and disease. As readers delve into the journal, they will access rigorous studies that not only enhance theoretical understanding but also pave the way for potential clinical applications, making it a crucial resource for those invested in the future of cardiovascular and hematological research.

Physiological Reports is a pioneering open-access journal published by WILEY, dedicated to advancing the field of physiology through the dissemination of high-quality research. Since its inception in 2013, this journal has provided a platform for innovative studies in both general physiology and medical physiology, making significant contributions to our understanding of biological processes. With an impact factor that reflects its growing influence—as evidenced by its placement in the Q2 category for physiology and medical physiology in 2023—Physiological Reports is positioned as a vital resource for researchers and practitioners alike. The journal encourages the submission of diverse studies ranging from cellular mechanisms to systemic physiology, presenting a unique opportunity for authors to reach a global audience without access barriers. It has established a reputation for rigorous peer review and timely publication, ensuring that cutting-edge research is readily available to stimulate further inquiry and collaboration in the scientific community.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

Welcome to the Korean Journal of Physiology & Pharmacology, a pivotal academic platform dedicated to advancing the disciplines of physiology and pharmacology. Published by the esteemed Korean Journal of Physiology & Pharmacology, this journal has been disseminating valuable research findings since its inception in 1997 and continues to be a critical resource for researchers, professionals, and students in South Korea and beyond. With an ISSN of 1226-4512 and E-ISSN of 2093-3827, it offers insights into various aspects of drug action and physiological mechanisms. Although this journal currently does not subscribe to Open Access, it plays a vital role in bridging the gap between experimental and clinical studies, receiving commendations for its quality. In the 2023 Scopus rankings, it is notably positioned in the Q3 quartile for Pharmacology and Q4 for Physiology, reflecting its commitment to excellence. As the journal converges towards its comprehensive coverage in 2024, it remains a cornerstone for those looking to engage deeply with critical developments in these fields.